title: Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation.
authors.forename: M
authors.initials: M
authors.lastname: Lindemann
authors.forename: P
authors.initials: P
authors.lastname: Schuett
authors.forename: T
authors.initials: T
authors.lastname: Moritz
authors.forename: H D
authors.initials: HD
authors.lastname: Ottinger
authors.forename: B
authors.initials: B
authors.lastname: Opalka
authors.forename: S
authors.initials: S
authors.lastname: Seeber
authors.forename: M R
authors.initials: MR
authors.lastname: Nowrousian
authors.forename: H
authors.initials: H
authors.lastname: Grosse-Wilde
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology*; D036102:Peripheral Blood Stem Cell Transplantation; D014182:Transplantation, Autologous